In vivo evaluation of 111In-DTPA-N-TIMP-2 in Kaposi sarcoma associated with HIV infection View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2001-06

AUTHORS

R. Kulasegaram, B. Giersing, C. Page, P. Blower, R. Williamson, B. Peters, M. O'Doherty

ABSTRACT

Matrix metalloproteinases are the major agents responsible for the degradation of extracellular matrix and are produced at high levels by transformed and tumour cells, where they participate in the metastatic process by allowing local invasion. They are also more active at sites of new normal growth and angiogenesis. In the early stages of Kaposi sarcoma (KS), in vitro studies have demonstrated that vascular invasion can be inhibited by inhibitors of matrix metalloproteinases. Imaging of visceral and cutaneous KS presents a problem and therefore the potential use of a labelled inhibitor of metalloproteinases, N-TIMP-2, with indium-111 was thought to present a possible imaging tool. The biokinetics, dosimetry and potential for imaging with (111)In-DTPA-N-TIMP-2 were assessed in five patients with HIV infection and KS. Between 103.1 and 108.0 MBq of this agent was injected into each patient, and the dynamic uptake over the kidneys was assessed, whole body scans were performed and blood samples were obtained. The clearance from the blood was rapid, with a first component half-time of 16.6±3.4 min and a second component half-time of 9.68±2.68 h. Two out of five patients experienced minor shivering but one of these patients was generally unwell before the study. The last three patients had no such problems. The tracer distributed predominantly to the kidneys and did not localise in other tissues. No KS lesions were clearly identified. (111)In-DTPA-N-TIMP-2 can be successfully prepared and administered to patients safely, with a biodistribution and dosimetry which would allow its use as an imaging tracer. It is unlikely to be of use for imaging KS, but may have a role in other tumours that produce matrix metalloproteinases. More... »

PAGES

756-761

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s002590100522

DOI

http://dx.doi.org/10.1007/s002590100522

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1047550545

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24777542


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Guy's and St Thomas' NHS Foundation Trust", 
          "id": "https://www.grid.ac/institutes/grid.420545.2", 
          "name": [
            "Academic Department of STD'S, Guys and St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, UK, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kulasegaram", 
        "givenName": "R.", 
        "id": "sg:person.01030753640.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01030753640.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Kent", 
          "id": "https://www.grid.ac/institutes/grid.9759.2", 
          "name": [
            "Biosciences Department, University of Kent, Canterbury CT2 7NJ, UK, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Giersing", 
        "givenName": "B.", 
        "id": "sg:person.07355026016.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07355026016.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Guy's and St Thomas' NHS Foundation Trust", 
          "id": "https://www.grid.ac/institutes/grid.420545.2", 
          "name": [
            "Department of Nuclear Medicine, Guys and St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, UK, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Page", 
        "givenName": "C.", 
        "id": "sg:person.01156605221.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156605221.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Kent", 
          "id": "https://www.grid.ac/institutes/grid.9759.2", 
          "name": [
            "Biosciences Department, University of Kent, Canterbury CT2 7NJ, UK, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Blower", 
        "givenName": "P.", 
        "id": "sg:person.01353130062.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01353130062.76"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Kent", 
          "id": "https://www.grid.ac/institutes/grid.9759.2", 
          "name": [
            "Biosciences Department, University of Kent, Canterbury CT2 7NJ, UK, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Williamson", 
        "givenName": "R.", 
        "id": "sg:person.0704406206.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704406206.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Guy's and St Thomas' NHS Foundation Trust", 
          "id": "https://www.grid.ac/institutes/grid.420545.2", 
          "name": [
            "Academic Department of STD'S, Guys and St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, UK, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Peters", 
        "givenName": "B.", 
        "id": "sg:person.012435233037.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012435233037.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Kent and Canterbury Hospital", 
          "id": "https://www.grid.ac/institutes/grid.415149.c", 
          "name": [
            "Department of Nuclear Medicine, Kent and Canterbury Hospital, Canterbury, Kent CT1 9NG, UK, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "O'Doherty", 
        "givenName": "M.", 
        "id": "sg:person.01370657456.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01370657456.77"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/s0065-1281(99)80031-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003459980"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1432-1033.1996.00476.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007008142"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002030-199409000-00004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017708099"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002030-199409000-00004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017708099"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002030-199807000-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018106163"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002030-199807000-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018106163"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002030-199710001-00007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022359548"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002030-199710001-00007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022359548"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1517/13543784.3.3.273", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038511954"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002030-199910220-00014", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041607755"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002030-199910220-00014", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041607755"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.271.29.17119", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042053748"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00042560-199807010-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043472681"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00042560-199807010-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043472681"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/83.11.775", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059816515"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002030-199715000-00022", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060144154"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002030-199715000-00022", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060144154"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002030-199715000-00022", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060144154"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2001-06", 
    "datePublishedReg": "2001-06-01", 
    "description": "Matrix metalloproteinases are the major agents responsible for the degradation of extracellular matrix and are produced at high levels by transformed and tumour cells, where they participate in the metastatic process by allowing local invasion. They are also more active at sites of new normal growth and angiogenesis. In the early stages of Kaposi sarcoma (KS), in vitro studies have demonstrated that vascular invasion can be inhibited by inhibitors of matrix metalloproteinases. Imaging of visceral and cutaneous KS presents a problem and therefore the potential use of a labelled inhibitor of metalloproteinases, N-TIMP-2, with indium-111 was thought to present a possible imaging tool. The biokinetics, dosimetry and potential for imaging with (111)In-DTPA-N-TIMP-2 were assessed in five patients with HIV infection and KS. Between 103.1 and 108.0\u00a0MBq of this agent was injected into each patient, and the dynamic uptake over the kidneys was assessed, whole body scans were performed and blood samples were obtained. The clearance from the blood was rapid, with a first component half-time of 16.6\u00b13.4\u00a0min and a second component half-time of 9.68\u00b12.68\u00a0h. Two out of five patients experienced minor shivering but one of these patients was generally unwell before the study. The last three patients had no such problems. The tracer distributed predominantly to the kidneys and did not localise in other tissues. No KS lesions were clearly identified. (111)In-DTPA-N-TIMP-2 can be successfully prepared and administered to patients safely, with a biodistribution and dosimetry which would allow its use as an imaging tracer. It is unlikely to be of use for imaging KS, but may have a role in other tumours that produce matrix metalloproteinases. ", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s002590100522", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1297401", 
        "issn": [
          "1619-7070", 
          "1619-7089"
        ], 
        "name": "European Journal of Nuclear Medicine and Molecular Imaging", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "28"
      }
    ], 
    "name": "In vivo evaluation of 111In-DTPA-N-TIMP-2 in Kaposi sarcoma associated with HIV infection", 
    "pagination": "756-761", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "e284590b450b61e51923fcfbf5db353a86812fc8eb365980ad6383e175947fa6"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24777542"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7606882"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s002590100522"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1047550545"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s002590100522", 
      "https://app.dimensions.ai/details/publication/pub.1047550545"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T19:09", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8678_00000515.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs002590100522"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s002590100522'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s002590100522'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s002590100522'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s002590100522'


 

This table displays all metadata directly associated to this object as RDF triples.

151 TRIPLES      21 PREDICATES      40 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s002590100522 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N64d638e749f740fca4b679d95605a1fa
4 schema:citation https://doi.org/10.1016/s0065-1281(99)80031-2
5 https://doi.org/10.1074/jbc.271.29.17119
6 https://doi.org/10.1093/jnci/83.11.775
7 https://doi.org/10.1097/00002030-199409000-00004
8 https://doi.org/10.1097/00002030-199710001-00007
9 https://doi.org/10.1097/00002030-199715000-00022
10 https://doi.org/10.1097/00002030-199807000-00002
11 https://doi.org/10.1097/00002030-199910220-00014
12 https://doi.org/10.1097/00042560-199807010-00002
13 https://doi.org/10.1111/j.1432-1033.1996.00476.x
14 https://doi.org/10.1517/13543784.3.3.273
15 schema:datePublished 2001-06
16 schema:datePublishedReg 2001-06-01
17 schema:description Matrix metalloproteinases are the major agents responsible for the degradation of extracellular matrix and are produced at high levels by transformed and tumour cells, where they participate in the metastatic process by allowing local invasion. They are also more active at sites of new normal growth and angiogenesis. In the early stages of Kaposi sarcoma (KS), in vitro studies have demonstrated that vascular invasion can be inhibited by inhibitors of matrix metalloproteinases. Imaging of visceral and cutaneous KS presents a problem and therefore the potential use of a labelled inhibitor of metalloproteinases, N-TIMP-2, with indium-111 was thought to present a possible imaging tool. The biokinetics, dosimetry and potential for imaging with (111)In-DTPA-N-TIMP-2 were assessed in five patients with HIV infection and KS. Between 103.1 and 108.0 MBq of this agent was injected into each patient, and the dynamic uptake over the kidneys was assessed, whole body scans were performed and blood samples were obtained. The clearance from the blood was rapid, with a first component half-time of 16.6±3.4 min and a second component half-time of 9.68±2.68 h. Two out of five patients experienced minor shivering but one of these patients was generally unwell before the study. The last three patients had no such problems. The tracer distributed predominantly to the kidneys and did not localise in other tissues. No KS lesions were clearly identified. (111)In-DTPA-N-TIMP-2 can be successfully prepared and administered to patients safely, with a biodistribution and dosimetry which would allow its use as an imaging tracer. It is unlikely to be of use for imaging KS, but may have a role in other tumours that produce matrix metalloproteinases.
18 schema:genre research_article
19 schema:inLanguage en
20 schema:isAccessibleForFree false
21 schema:isPartOf N61bd486efc2f4104bfdff0f095732376
22 Nb8056b97368e48cc9e6064140f258764
23 sg:journal.1297401
24 schema:name In vivo evaluation of 111In-DTPA-N-TIMP-2 in Kaposi sarcoma associated with HIV infection
25 schema:pagination 756-761
26 schema:productId N0a6e14fd5f09471494b1d2f052091079
27 N497097ab488143eeae870d2a8a8c5a79
28 N570ac37f20ba43d3bb608aa907d0f8d4
29 N696751992dd3473d88da9ca0384ae6c0
30 N93d1d4bbf1f9471bb126c3ea8ddd54dc
31 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047550545
32 https://doi.org/10.1007/s002590100522
33 schema:sdDatePublished 2019-04-10T19:09
34 schema:sdLicense https://scigraph.springernature.com/explorer/license/
35 schema:sdPublisher N98fbd16007974c1e9d7dcb3bc59fee79
36 schema:url http://link.springer.com/10.1007%2Fs002590100522
37 sgo:license sg:explorer/license/
38 sgo:sdDataset articles
39 rdf:type schema:ScholarlyArticle
40 N0a6e14fd5f09471494b1d2f052091079 schema:name pubmed_id
41 schema:value 24777542
42 rdf:type schema:PropertyValue
43 N2b3fad0f11d04c4ca04430c520051ec0 rdf:first sg:person.012435233037.01
44 rdf:rest Naaa8c34b73af4232acad190dce458cf2
45 N497097ab488143eeae870d2a8a8c5a79 schema:name dimensions_id
46 schema:value pub.1047550545
47 rdf:type schema:PropertyValue
48 N570ac37f20ba43d3bb608aa907d0f8d4 schema:name doi
49 schema:value 10.1007/s002590100522
50 rdf:type schema:PropertyValue
51 N5951fb6f5bf2417497bf20f6119261fd rdf:first sg:person.0704406206.37
52 rdf:rest N2b3fad0f11d04c4ca04430c520051ec0
53 N61bd486efc2f4104bfdff0f095732376 schema:volumeNumber 28
54 rdf:type schema:PublicationVolume
55 N64d638e749f740fca4b679d95605a1fa rdf:first sg:person.01030753640.17
56 rdf:rest N95bea588397f457895524ec8beb1a05e
57 N696751992dd3473d88da9ca0384ae6c0 schema:name readcube_id
58 schema:value e284590b450b61e51923fcfbf5db353a86812fc8eb365980ad6383e175947fa6
59 rdf:type schema:PropertyValue
60 N93d1d4bbf1f9471bb126c3ea8ddd54dc schema:name nlm_unique_id
61 schema:value 7606882
62 rdf:type schema:PropertyValue
63 N95bea588397f457895524ec8beb1a05e rdf:first sg:person.07355026016.37
64 rdf:rest Nd9f7397e985b48eab8e03ae2f453b27c
65 N98fbd16007974c1e9d7dcb3bc59fee79 schema:name Springer Nature - SN SciGraph project
66 rdf:type schema:Organization
67 Na822c08f0c254477a61f674de3516d56 rdf:first sg:person.01353130062.76
68 rdf:rest N5951fb6f5bf2417497bf20f6119261fd
69 Naaa8c34b73af4232acad190dce458cf2 rdf:first sg:person.01370657456.77
70 rdf:rest rdf:nil
71 Nb8056b97368e48cc9e6064140f258764 schema:issueNumber 6
72 rdf:type schema:PublicationIssue
73 Nd9f7397e985b48eab8e03ae2f453b27c rdf:first sg:person.01156605221.02
74 rdf:rest Na822c08f0c254477a61f674de3516d56
75 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
76 schema:name Medical and Health Sciences
77 rdf:type schema:DefinedTerm
78 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
79 schema:name Clinical Sciences
80 rdf:type schema:DefinedTerm
81 sg:journal.1297401 schema:issn 1619-7070
82 1619-7089
83 schema:name European Journal of Nuclear Medicine and Molecular Imaging
84 rdf:type schema:Periodical
85 sg:person.01030753640.17 schema:affiliation https://www.grid.ac/institutes/grid.420545.2
86 schema:familyName Kulasegaram
87 schema:givenName R.
88 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01030753640.17
89 rdf:type schema:Person
90 sg:person.01156605221.02 schema:affiliation https://www.grid.ac/institutes/grid.420545.2
91 schema:familyName Page
92 schema:givenName C.
93 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156605221.02
94 rdf:type schema:Person
95 sg:person.012435233037.01 schema:affiliation https://www.grid.ac/institutes/grid.420545.2
96 schema:familyName Peters
97 schema:givenName B.
98 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012435233037.01
99 rdf:type schema:Person
100 sg:person.01353130062.76 schema:affiliation https://www.grid.ac/institutes/grid.9759.2
101 schema:familyName Blower
102 schema:givenName P.
103 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01353130062.76
104 rdf:type schema:Person
105 sg:person.01370657456.77 schema:affiliation https://www.grid.ac/institutes/grid.415149.c
106 schema:familyName O'Doherty
107 schema:givenName M.
108 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01370657456.77
109 rdf:type schema:Person
110 sg:person.0704406206.37 schema:affiliation https://www.grid.ac/institutes/grid.9759.2
111 schema:familyName Williamson
112 schema:givenName R.
113 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704406206.37
114 rdf:type schema:Person
115 sg:person.07355026016.37 schema:affiliation https://www.grid.ac/institutes/grid.9759.2
116 schema:familyName Giersing
117 schema:givenName B.
118 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07355026016.37
119 rdf:type schema:Person
120 https://doi.org/10.1016/s0065-1281(99)80031-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003459980
121 rdf:type schema:CreativeWork
122 https://doi.org/10.1074/jbc.271.29.17119 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042053748
123 rdf:type schema:CreativeWork
124 https://doi.org/10.1093/jnci/83.11.775 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059816515
125 rdf:type schema:CreativeWork
126 https://doi.org/10.1097/00002030-199409000-00004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017708099
127 rdf:type schema:CreativeWork
128 https://doi.org/10.1097/00002030-199710001-00007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022359548
129 rdf:type schema:CreativeWork
130 https://doi.org/10.1097/00002030-199715000-00022 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060144154
131 rdf:type schema:CreativeWork
132 https://doi.org/10.1097/00002030-199807000-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018106163
133 rdf:type schema:CreativeWork
134 https://doi.org/10.1097/00002030-199910220-00014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041607755
135 rdf:type schema:CreativeWork
136 https://doi.org/10.1097/00042560-199807010-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043472681
137 rdf:type schema:CreativeWork
138 https://doi.org/10.1111/j.1432-1033.1996.00476.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1007008142
139 rdf:type schema:CreativeWork
140 https://doi.org/10.1517/13543784.3.3.273 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038511954
141 rdf:type schema:CreativeWork
142 https://www.grid.ac/institutes/grid.415149.c schema:alternateName Kent and Canterbury Hospital
143 schema:name Department of Nuclear Medicine, Kent and Canterbury Hospital, Canterbury, Kent CT1 9NG, UK, UK
144 rdf:type schema:Organization
145 https://www.grid.ac/institutes/grid.420545.2 schema:alternateName Guy's and St Thomas' NHS Foundation Trust
146 schema:name Academic Department of STD'S, Guys and St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, UK, UK
147 Department of Nuclear Medicine, Guys and St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, UK, UK
148 rdf:type schema:Organization
149 https://www.grid.ac/institutes/grid.9759.2 schema:alternateName University of Kent
150 schema:name Biosciences Department, University of Kent, Canterbury CT2 7NJ, UK, UK
151 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...